Testosterone Lawsuit News: Plaintiffs File New AndroGel Motion in Federal Litigation, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing numerous testosterone lawsuit plaintiffs who allegedly suffered serious cardiovascular complications due to their use of AndroGel and other low testosterone therapy medications.

Free Case Review
Our Firm is representing numerous testosterone lawsuit plaintiffs who were allegedly harmed by AndroGel and other prescription testosterone medications. We are pleased to see this litigation moving forward, and will be monitoring this matter closely.

Hundreds of testosterone lawsuits (http://www.testosteronelawsuithub.com/) that allege medications like AndroGel caused plaintiffs to experience serious cardiovascular complications continue to move forward in a multidistrict litigation now underway in U.S. District Court, Northern District of Illinois, Bernstein Liebhard LLP reports. According to a motion filed with the Court on January 16th, plaintiffs are seeking to compel the production of files and documents relevant to AndroGel lawsuits, including those pertaining to the means in which the drug was marketed. In a response filed with the Court of February 6th, Abbvie Inc. maintains that the plaintiffs’ requests are overly broad, and that the company requires more time to respond. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is representing numerous testosterone lawsuit plaintiffs who were allegedly harmed by AndroGel and other prescription testosterone medications. We are pleased to see this litigation moving forward, and will be monitoring this matter closely,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by AndroGel and other low testosterone treatments.

Testosterone Litigation
Court records indicate that the testosterone litigation has been growing since the U.S. Food & Drug Administration (FDA) revealed on January 31, 2014 that it was reviewing the cardiovascular side effects allegedly associated with low testosterone therapy. Plaintiffs involved in the federal proceeding claim that their use of drugs like AndroGel caused heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems. They further allege that the manufacturers of the medications knowingly concealed information about these side effects from the public, and failed to adequately warn doctors and patients about the potential for life-threatening heart complications. The lawsuits also assert that healthy men were induced to use low testosterone treatments by misleading marketing claims that positioned the drugs as effective remedies for symptoms associated with male aging.

In September, a panel of FDA advisors recommended that the safety labeling for all testosterone medications be revised to make clear they have not been shown to lessen symptoms associated with male aging, such as low sex drive, fatigue, and muscle loss. They also recommended that the manufacturers of testosterone replacement therapies be required to conduct studies of their cardiovascular side effects.*

Men who allegedly suffered serious cardiovascular events due to their use of prescription testosterone treatments may be entitled to compensation for their injury-related damages. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*http://reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 17, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website